HEADER OXIDOREDUCTASE 09-NOV-02 1N6B TITLE MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL TITLE 2 DERIVATIVE OF SULFAPHENAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 2C5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYPIIC5, P450 1, PROGESTERONE 21-HYDROXYLASE, P450IIC5; COMPND 5 EC: 1.14.14.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 ORGAN: LIVER; SOURCE 6 GENE: CYP2C5; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCW KEYWDS MEMBRANE PROTEIN, PROGESTERONE 21-HYDROXYLASE, BENZO(A), PYRENE KEYWDS 2 HYDROXYLASE, ESTRADIOL 2-HYDROXYLASE, P450, CYP2C5, KEYWDS 3 DIMETHYLSULFAPHENAZOLE COMPLEX, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.R.WESTER,E.F.JOHNSON,C.MARQUES-SOARES,P.M.DANSETTE,D.MANSUY, AUTHOR 2 C.D.STOUT REVDAT 5 14-FEB-24 1N6B 1 REMARK REVDAT 4 27-OCT-21 1N6B 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 1N6B 1 VERSN REVDAT 2 24-FEB-09 1N6B 1 VERSN REVDAT 1 03-JUN-03 1N6B 0 JRNL AUTH M.R.WESTER,E.F.JOHNSON,C.MARQUES-SOARES,P.M.DANSETTE, JRNL AUTH 2 D.MANSUY,C.D.STOUT JRNL TITL STRUCTURE OF A SUBSTRATE COMPLEX OF MAMMALIAN CYTOCHROME JRNL TITL 2 P450 2C5 AT 2.3 A RESOLUTION: EVIDENCE FOR MULTIPLE JRNL TITL 3 SUBSTRATE BINDING MODES JRNL REF BIOCHEMISTRY V. 42 6370 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12767218 JRNL DOI 10.1021/BI0273922 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.A.WILLIAMS,J.COSME,V.SRIDHAR,E.F.JOHNSON,D.E.MCREE REMARK 1 TITL MAMMALIAN MICROSOMAL CYTOCHROME P450 MONOOXYGENASE: REMARK 1 TITL 2 STRUCTURAL ADAPTATIONS FOR MEMBRANE BINDING AND FUNCTIONAL REMARK 1 TITL 3 DIVERSITY REMARK 1 REF MOL.CELL V. 5 121 2000 REMARK 1 REFN ISSN 1097-2765 REMARK 1 DOI 10.1016/S1097-2765(00)80408-6 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.COSME,E.F.JOHNSON REMARK 1 TITL ENGINEERING MICROSOMAL CYTOCHROME P450 2C5 TO BE A SOLUBLE, REMARK 1 TITL 2 MONOMERIC ENZYME. MUTATIONS THAT ALTER AGGREGATION, REMARK 1 TITL 3 PHOSPHOLIPID DEPENDENCE OF CATALYSIS, AND MEMBRANE BINDING REMARK 1 REF J.BIOL.CHEM. V. 275 2545 2000 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.275.4.2545 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 37253 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1698 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3697 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.290 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N6B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1000017572. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37253 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : 0.05800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.47900 REMARK 200 R SYM FOR SHELL (I) : 0.47900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1DT6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, CYMAL5, PH 7.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.16500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.14500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 85.92000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.16500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.14500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 85.92000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.16500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 67.14500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 85.92000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.16500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 67.14500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 85.92000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 75480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -242.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 678 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 19 REMARK 465 ALA A 20 REMARK 465 LYS A 21 REMARK 465 LYS A 22 REMARK 465 THR A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 LYS A 26 REMARK 465 HIS A 489 REMARK 465 HIS A 490 REMARK 465 HIS A 491 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 28 161.93 76.18 REMARK 500 PRO A 31 -158.64 -64.44 REMARK 500 PRO A 33 107.80 -52.28 REMARK 500 THR A 34 118.73 -31.32 REMARK 500 PRO A 35 105.39 -55.52 REMARK 500 ILE A 38 -86.98 81.42 REMARK 500 ILE A 39 41.28 -84.95 REMARK 500 ASP A 49 70.65 -158.95 REMARK 500 VAL A 88 -70.10 -96.93 REMARK 500 LEU A 90 45.36 -103.46 REMARK 500 ALA A 95 11.22 -64.44 REMARK 500 LEU A 110 -164.45 -109.42 REMARK 500 ALA A 117 -135.43 41.68 REMARK 500 GLU A 272 -117.13 -87.59 REMARK 500 GLN A 273 -1.02 -53.60 REMARK 500 THR A 296 -60.43 -90.66 REMARK 500 ASN A 362 -153.49 57.63 REMARK 500 ARG A 374 -116.35 66.75 REMARK 500 LYS A 380 123.45 -35.18 REMARK 500 SER A 426 -167.87 72.16 REMARK 500 CYS A 432 134.64 -32.51 REMARK 500 ASN A 471 -79.70 -66.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 432 SG REMARK 620 2 HEM A 500 NA 95.5 REMARK 620 3 HEM A 500 NB 93.5 89.6 REMARK 620 4 HEM A 500 NC 82.8 177.7 92.0 REMARK 620 5 HEM A 500 ND 91.3 90.0 175.2 88.5 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMZ A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DT6 RELATED DB: PDB REMARK 900 MICROSOMAL CYTOCHROME P450 2C5/3LVDH WITHOUT SUBSTRATE AT 3.0 REMARK 900 RESOLUTION DBREF 1N6B A 27 487 UNP P00179 CP2C5_RABIT 27 487 SEQADV 1N6B MET A 19 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B ALA A 20 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B LYS A 21 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B LYS A 22 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B THR A 23 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B SER A 24 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B SER A 25 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B LYS A 26 UNP P00179 ENGINEERED MUTATION SEQADV 1N6B HIS A 202 UNP P00179 ASN 202 ENGINEERED MUTATION SEQADV 1N6B GLU A 206 UNP P00179 ARG 206 ENGINEERED MUTATION SEQADV 1N6B LEU A 207 UNP P00179 ILE 207 ENGINEERED MUTATION SEQADV 1N6B GLY A 209 UNP P00179 SER 209 ENGINEERED MUTATION SEQADV 1N6B THR A 210 UNP P00179 SER 210 ENGINEERED MUTATION SEQADV 1N6B HIS A 488 UNP P00179 EXPRESSION TAG SEQADV 1N6B HIS A 489 UNP P00179 EXPRESSION TAG SEQADV 1N6B HIS A 490 UNP P00179 EXPRESSION TAG SEQADV 1N6B HIS A 491 UNP P00179 EXPRESSION TAG SEQRES 1 A 473 MET ALA LYS LYS THR SER SER LYS GLY LYS LEU PRO PRO SEQRES 2 A 473 GLY PRO THR PRO PHE PRO ILE ILE GLY ASN ILE LEU GLN SEQRES 3 A 473 ILE ASP ALA LYS ASP ILE SER LYS SER LEU THR LYS PHE SEQRES 4 A 473 SER GLU CYS TYR GLY PRO VAL PHE THR VAL TYR LEU GLY SEQRES 5 A 473 MET LYS PRO THR VAL VAL LEU HIS GLY TYR GLU ALA VAL SEQRES 6 A 473 LYS GLU ALA LEU VAL ASP LEU GLY GLU GLU PHE ALA GLY SEQRES 7 A 473 ARG GLY SER VAL PRO ILE LEU GLU LYS VAL SER LYS GLY SEQRES 8 A 473 LEU GLY ILE ALA PHE SER ASN ALA LYS THR TRP LYS GLU SEQRES 9 A 473 MET ARG ARG PHE SER LEU MET THR LEU ARG ASN PHE GLY SEQRES 10 A 473 MET GLY LYS ARG SER ILE GLU ASP ARG ILE GLN GLU GLU SEQRES 11 A 473 ALA ARG CYS LEU VAL GLU GLU LEU ARG LYS THR ASN ALA SEQRES 12 A 473 SER PRO CYS ASP PRO THR PHE ILE LEU GLY CYS ALA PRO SEQRES 13 A 473 CYS ASN VAL ILE CYS SER VAL ILE PHE HIS ASN ARG PHE SEQRES 14 A 473 ASP TYR LYS ASP GLU GLU PHE LEU LYS LEU MET GLU SER SEQRES 15 A 473 LEU HIS GLU ASN VAL GLU LEU LEU GLY THR PRO TRP LEU SEQRES 16 A 473 GLN VAL TYR ASN ASN PHE PRO ALA LEU LEU ASP TYR PHE SEQRES 17 A 473 PRO GLY ILE HIS LYS THR LEU LEU LYS ASN ALA ASP TYR SEQRES 18 A 473 ILE LYS ASN PHE ILE MET GLU LYS VAL LYS GLU HIS GLN SEQRES 19 A 473 LYS LEU LEU ASP VAL ASN ASN PRO ARG ASP PHE ILE ASP SEQRES 20 A 473 CYS PHE LEU ILE LYS MET GLU GLN GLU ASN ASN LEU GLU SEQRES 21 A 473 PHE THR LEU GLU SER LEU VAL ILE ALA VAL SER ASP LEU SEQRES 22 A 473 PHE GLY ALA GLY THR GLU THR THR SER THR THR LEU ARG SEQRES 23 A 473 TYR SER LEU LEU LEU LEU LEU LYS HIS PRO GLU VAL ALA SEQRES 24 A 473 ALA ARG VAL GLN GLU GLU ILE GLU ARG VAL ILE GLY ARG SEQRES 25 A 473 HIS ARG SER PRO CYS MET GLN ASP ARG SER ARG MET PRO SEQRES 26 A 473 TYR THR ASP ALA VAL ILE HIS GLU ILE GLN ARG PHE ILE SEQRES 27 A 473 ASP LEU LEU PRO THR ASN LEU PRO HIS ALA VAL THR ARG SEQRES 28 A 473 ASP VAL ARG PHE ARG ASN TYR PHE ILE PRO LYS GLY THR SEQRES 29 A 473 ASP ILE ILE THR SER LEU THR SER VAL LEU HIS ASP GLU SEQRES 30 A 473 LYS ALA PHE PRO ASN PRO LYS VAL PHE ASP PRO GLY HIS SEQRES 31 A 473 PHE LEU ASP GLU SER GLY ASN PHE LYS LYS SER ASP TYR SEQRES 32 A 473 PHE MET PRO PHE SER ALA GLY LYS ARG MET CYS VAL GLY SEQRES 33 A 473 GLU GLY LEU ALA ARG MET GLU LEU PHE LEU PHE LEU THR SEQRES 34 A 473 SER ILE LEU GLN ASN PHE LYS LEU GLN SER LEU VAL GLU SEQRES 35 A 473 PRO LYS ASP LEU ASP ILE THR ALA VAL VAL ASN GLY PHE SEQRES 36 A 473 VAL SER VAL PRO PRO SER TYR GLN LEU CYS PHE ILE PRO SEQRES 37 A 473 ILE HIS HIS HIS HIS HET SO4 A 502 5 HET SO4 A 503 5 HET HEM A 500 43 HET DMZ A 501 46 HETNAM SO4 SULFATE ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM DMZ 4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL) HETNAM 2 DMZ BENZENESULFONAMIDE HETSYN HEM HEME HETSYN DMZ DIMETHYLSULFAPHENAZOLE FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 HEM C34 H32 FE N4 O4 FORMUL 5 DMZ C17 H17 N3 O2 S FORMUL 6 HOH *118(H2 O) HELIX 1 1 ASN A 41 ILE A 45 5 5 HELIX 2 2 ASP A 49 GLY A 62 1 14 HELIX 3 3 GLY A 79 VAL A 88 1 10 HELIX 4 4 LEU A 90 ALA A 95 1 6 HELIX 5 5 VAL A 100 SER A 107 1 8 HELIX 6 6 ASN A 116 LEU A 131 1 16 HELIX 7 7 SER A 140 LYS A 158 1 19 HELIX 8 8 PHE A 168 HIS A 184 1 17 HELIX 9 9 ASP A 191 GLY A 209 1 19 HELIX 10 10 GLN A 214 PHE A 219 1 6 HELIX 11 11 PRO A 220 PHE A 226 1 7 HELIX 12 12 PHE A 226 LEU A 254 1 29 HELIX 13 13 ASP A 262 MET A 271 1 10 HELIX 14 14 THR A 280 HIS A 313 1 34 HELIX 15 15 HIS A 313 ILE A 328 1 16 HELIX 16 16 MET A 336 ARG A 341 1 6 HELIX 17 17 MET A 342 ASP A 357 1 16 HELIX 18 18 LEU A 388 HIS A 393 1 6 HELIX 19 19 ASP A 405 LEU A 410 5 6 HELIX 20 20 GLY A 434 ASN A 452 1 19 HELIX 21 21 GLU A 460 LEU A 464 5 5 SHEET 1 A 5 VAL A 64 TYR A 68 0 SHEET 2 A 5 PRO A 73 HIS A 78 -1 O VAL A 76 N PHE A 65 SHEET 3 A 5 ASP A 383 SER A 387 1 O ILE A 385 N LEU A 77 SHEET 4 A 5 HIS A 365 ALA A 366 -1 N HIS A 365 O ILE A 384 SHEET 5 A 5 GLY A 96 ARG A 97 -1 N GLY A 96 O ALA A 366 SHEET 1 B 2 VAL A 371 PHE A 373 0 SHEET 2 B 2 TYR A 376 ILE A 378 -1 O ILE A 378 N VAL A 371 SHEET 1 C 2 PHE A 453 GLN A 456 0 SHEET 2 C 2 CYS A 483 PRO A 486 -1 O CYS A 483 N GLN A 456 SHEET 1 D 2 VAL A 469 VAL A 470 0 SHEET 2 D 2 SER A 475 VAL A 476 -1 O VAL A 476 N VAL A 469 LINK SG CYS A 432 FE HEM A 500 1555 1555 2.32 SITE 1 AC1 4 ARG A 132 ASN A 133 LYS A 454 HOH A 813 SITE 1 AC2 2 ASP A 411 GLU A 412 SITE 1 AC3 18 ARG A 97 ILE A 112 TRP A 120 ARG A 124 SITE 2 AC3 18 ALA A 294 GLY A 295 THR A 298 THR A 299 SITE 3 AC3 18 THR A 302 LEU A 358 ASN A 362 HIS A 365 SITE 4 AC3 18 PRO A 424 PHE A 425 SER A 426 ARG A 430 SITE 5 AC3 18 CYS A 432 GLY A 434 SITE 1 AC4 10 LEU A 103 PHE A 114 LEU A 201 ASN A 204 SITE 2 AC4 10 VAL A 205 SER A 289 ASP A 290 GLY A 293 SITE 3 AC4 10 ALA A 294 PHE A 473 CRYST1 74.330 134.290 171.840 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013454 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007447 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005819 0.00000